166 related articles for article (PubMed ID: 33522595)
41. Gamma irradiating chromatography columns enables bioburden-free integrated continuous biomanufacturing.
Varner C; Patil R; Godawat R; Warikoo V; Konstantinov K; Brower KP
Biotechnol J; 2021 Apr; 16(4):e2000298. PubMed ID: 33314754
[TBL] [Abstract][Full Text] [Related]
42. Engineering death resistance in CHO cells for improved perfusion culture.
MacDonald MA; Nöbel M; Martínez VS; Baker K; Shave E; Gray PP; Mahler S; Munro T; Nielsen LK; Marcellin E
MAbs; 2022; 14(1):2083465. PubMed ID: 35737825
[TBL] [Abstract][Full Text] [Related]
43. Side-by-side comparability of batch and continuous downstream for the production of monoclonal antibodies.
David L; Schwan P; Lobedann M; Borchert SO; Budde B; Temming M; Kuerschner M; Alberti Aguilo FM; Baumarth K; Thüte T; Maiser B; Blank A; Kistler V; Weber N; Brandt H; Poggel M; Kaiser K; Geisen K; Oehme F; Schembecker G
Biotechnol Bioeng; 2020 Apr; 117(4):1024-1036. PubMed ID: 31930482
[TBL] [Abstract][Full Text] [Related]
44. A new large-scale manufacturing platform for complex biopharmaceuticals.
Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
[TBL] [Abstract][Full Text] [Related]
45. Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up.
Girard V; Hilbold NJ; Ng CK; Pegon L; Chahim W; Rousset F; Monchois V
J Biotechnol; 2015 Nov; 213():65-73. PubMed ID: 25962790
[TBL] [Abstract][Full Text] [Related]
46. Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.
Xu J; Xu X; Huang C; Angelo J; Oliveira CL; Xu M; Xu X; Temel D; Ding J; Ghose S; Borys MC; Li ZJ
MAbs; 2020 Jan; 12(1):1770669. PubMed ID: 32425110
[TBL] [Abstract][Full Text] [Related]
47. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
[TBL] [Abstract][Full Text] [Related]
48. Transfer of continuous manufacturing process principles for mAb production in a GMP environment: A step in the transition from batch to continuous.
Botelho Ferreira K; Benlegrimet A; Diane G; Pasquier V; Guillot R; De Poli M; Chappuis L; Vishwanathan N; Souquet J; Broly H; Bielser JM
Biotechnol Prog; 2022 Jul; 38(4):e3259. PubMed ID: 35412696
[TBL] [Abstract][Full Text] [Related]
49. How to Produce mAbs in a Cube-Shaped Stirred Single-Use Bioreactor at 200 L Scale.
Schirmer C; Müller J; Steffen N; Werner S; Eibl R; Eibl D
Methods Mol Biol; 2020; 2095():169-186. PubMed ID: 31858468
[TBL] [Abstract][Full Text] [Related]
50. Equipment and Analytical Companies Meeting Continuous Challenges May 20-21 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-831. PubMed ID: 28756844
[TBL] [Abstract][Full Text] [Related]
51. Developing the biofacility of the future based on continuous processing and single-use technology.
Klutz S; Magnus J; Lobedann M; Schwan P; Maiser B; Niklas J; Temming M; Schembecker G
J Biotechnol; 2015 Nov; 213():120-30. PubMed ID: 26091773
[TBL] [Abstract][Full Text] [Related]
52. Transfer of a three step mAb chromatography process from batch to continuous: Optimizing productivity to minimize consumable requirements.
Gjoka X; Gantier R; Schofield M
J Biotechnol; 2017 Jan; 242():11-18. PubMed ID: 27939321
[TBL] [Abstract][Full Text] [Related]
53. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
Xenopoulos A
J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
[TBL] [Abstract][Full Text] [Related]
54. Developments and opportunities in continuous biopharmaceutical manufacturing.
Khanal O; Lenhoff AM
MAbs; 2021; 13(1):1903664. PubMed ID: 33843449
[TBL] [Abstract][Full Text] [Related]
55. Model-assisted process design for better evaluation and scaling up of continuous downstream bioprocessing.
Shi C; Chen XJ; Jiao B; Liu P; Jing SY; Zhong XZ; Chen R; Gong W; Lin DQ
J Chromatogr A; 2022 Nov; 1683():463532. PubMed ID: 36191362
[TBL] [Abstract][Full Text] [Related]
56. Development of a scale-up strategy for Chinese hamster ovary cell culture processes using the k
Doi T; Kajihara H; Chuman Y; Kuwae S; Kaminagayoshi T; Omasa T
Biotechnol Prog; 2020 Sep; 36(5):e3000. PubMed ID: 32298540
[TBL] [Abstract][Full Text] [Related]
57. Control of surge tanks for continuous manufacturing of monoclonal antibodies.
Thakur G; Nikita S; Tiwari A; Rathore AS
Biotechnol Bioeng; 2021 May; 118(5):1913-1931. PubMed ID: 33547800
[TBL] [Abstract][Full Text] [Related]
58. Model-based design and control of a small-scale integrated continuous end-to-end mAb platform.
Gomis-Fons J; Schwarz H; Zhang L; Andersson N; Nilsson B; Castan A; Solbrand A; Stevenson J; Chotteau V
Biotechnol Prog; 2020 Jul; 36(4):e2995. PubMed ID: 32233078
[TBL] [Abstract][Full Text] [Related]
59. Hydrocyclones as cell retention device for CHO perfusion processes in single-use bioreactors.
Bettinardi IW; Castan A; Medronho RA; Castilho LR
Biotechnol Bioeng; 2020 Jul; 117(7):1915-1928. PubMed ID: 32181883
[TBL] [Abstract][Full Text] [Related]
60. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
